Bard C R Inc Receivables Turnover Ratio (BCR), from the third quarter 2017 to the third quarter 2016 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bard C R Inc  (BCR)
 

Bard C R Inc Accounts Receivables Turnover Ratio from the third quarter 2017 to the third quarter 2016

Quarterly Results, Trends, Rankings, Statistics


Bard C R Inc's ability to collect accounts receivable sequentially worsen to 8.13, indicating more challenging environment then in the second quarter 2017, but still, it is a far cry from any concerns. Bard C R Inc's Accounts Receivable average collection period in the Sep 30 2017 quarter, has increased to 45 days, from 44 days, in the Jun 30 2017 quarter.

If we take a look into Healthcare sector 173 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2017 from 1680 to 1756.

What is Receivable Turnover Ratio?
What is Bard C R Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BCR Receivables Turnover Ratio (Sep 30 2017)
III. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
I. Quarter		 (Dec 31 2016)
IV. Quarter		 (Sep 30 2016)
III. Quarter
Y / Y Receivable Change 10.36 % 2.03 % -1.77 % 7.23 % 3.15 %
Y / Y Revenue Change 5.09 % 5.17 % 7.48 % 11.06 % 8.8 %
Receivable Turnover Ratio (TTM) 8.13 8.23 8.17 7.99 7.92
BCR's Total Ranking # 1756 # 1680 # 1680 # 1618 # 1400
Accounts Receivable average collection period days 45 44 45 46 46
Seq. Receivable Change 5.52 % 5.93 % -5.72 % 4.72 % -2.44 %
Seq. Revenue Change 1.03 % 4.36 % -2.93 % 2.68 % 1.12 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 76
Healthcare Sector # 174
Overall Market # 1756

Receivable Turnover Ratio Statistics
High Average Low
0.95 0.81 0.64
(Dec. 31, 2008)   (Sep. 28, 2014)





BCR Company Profile • Back to BCR Efficiency Comparisons • Compare BCR Receivables Turnover Ratio to its Competitors

Financial Statements
Bard C R Inc's Accounts Receivable $ 503 Millions Visit BCR's Balance sheet
Bard C R Inc's Sales TTM $ 3,875 Millions Visit BCR's Income Statement
Sources of BCR's Revenues Visit BCR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BCR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BCR's Growth Rates BCR's Roa BCR's Inventory Turnover Ratio BCR's Dividend Comparisons
BCR's Profitability Ratios BCR's Roi BCR's Asset Turnover Ratio BCR's Dividend Growth
BCR's Valuation Ratios BCR's Roe BCR's Financial Strength Ratios BCR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2017, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2017 Receivable at quarter ending Sep 30 2017
Neurometrix Inc   20.51 $ 15.878  Millions$ 0.774  Millions
Nuvalent Inc   19.88 $ 3.450  Millions$ 0.174  Millions
Cardiff Lexington Corporation  19.60 $ 1.708  Millions$ 0.087  Millions
Durect Corp  19.51 $ 33.149  Millions$ 1.699  Millions
Invitae Corporation  19.41 $ 52.058  Millions$ 2.683  Millions
Cv Sciences Inc   19.29 $ 16.377  Millions$ 0.849  Millions
Bioxytran Inc   18.93 $ 0.217  Millions$ 0.011  Millions
Kushco Holdings Inc   18.76 $ 18.799  Millions$ 1.002  Millions
Cytokinetics Incorporated  18.61 $ 46.524  Millions$ 2.500  Millions
Opiant Pharmaceuticals Inc   18.50 $ 17.347  Millions$ 0.938  Millions
Kadmon holdings inc   18.48 $ 15.077  Millions$ 0.816  Millions
Regenxbio Inc   18.32 $ 10.049  Millions$ 0.549  Millions
United Cannabis Corp  17.21 $ 0.464  Millions$ 0.027  Millions
Editas Medicine Inc   17.20 $ 10.959  Millions$ 0.637  Millions
Skinvisible Inc   16.67 $ 0.141  Millions$ 0.008  Millions
Immune Design Corp.  16.43 $ 8.768  Millions$ 0.534  Millions
Dyne Therapeutics Inc   16.43 $ 6,977.000  Millions$ 424.750  Millions
Timber Pharmaceuticals Inc   16.24 $ 0.069  Millions$ 0.004  Millions
Caredx Inc   15.03 $ 46.680  Millions$ 3.105  Millions
Aptevo Therapeutics Inc   14.90 $ 27.847  Millions$ 1.869  Millions
Jaguar Health Inc   14.67 $ 2.848  Millions$ 0.194  Millions
Oncomed Pharmaceuticals Inc  14.59 $ 23.733  Millions$ 1.626  Millions
Chemed Corporation  14.56 $ 1,641.843  Millions$ 112.784  Millions
Procyon Corporation  14.30 $ 3.964  Millions$ 0.277  Millions
Xoma Royalty Corporation  14.11 $ 47.857  Millions$ 3.392  Millions
Integrated Biopharma Inc  14.06 $ 44.043  Millions$ 3.133  Millions
Heartbeam Inc   14.02 $ 248.990  Millions$ 17.758  Millions
Theravance Biopharma inc   13.80 $ 16.563  Millions$ 1.200  Millions
Icagen, Inc.  13.76 $ 22.645  Millions$ 1.645  Millions
Davita Inc   13.49 $ 25,452.150  Millions$ 1,887.349  Millions

Date modified: 2026-09-08T15:08:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.